Product Images Teriflunomide
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Teriflunomide NDC 0480-3156 by Teva Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
1 - image 1
1 - image 2
This appears to be a table showing the results of a study comparing the effectiveness of Teriflunomide versus a placebo. The table lists the number of participants at risk and the weeks of the study. There are also percentages indicating the effectiveness of Teriflunomide versus the placebo. However, without more context, it is unclear what the study was for or what the percentages represent.*
1 - image 3
This is a data table showing the percentage of sustained disability progression for 12 weeks for Placebo, 7mg Teriflunomide, and 14mg Teriflunomide. The results indicate that compared to the placebo, there is a significant difference in disability progression for those treated with 14mg of Teriflunomide. The table also lists the number of people at risk for each treatment group during the specified time periods.*
1 - image 4
This is a description of a medicine package with 30 tablets and a Lot/Exp coding area. The medicine is available only by prescription and has a GTIN number of 00304803157566. The package also has a revision number of A 912022 and a part number of 32089983-01.*
1 - image 5
This is a label of medication, specifically Teriflunomide tablets. It contains information such as the lot number, expiration date, and instructions for pharmacists to dispense to patients.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.